Kaneka Q1 Report 2022

In this business environment, the Kaneka Group’s business performance for 1Q was as follows. Consolidated net sales amounted to ¥192,739 million (up 17.4% year-on-year), operating income was ¥12,212 million (up 3.1% year-on-year), and ordinary income was ¥14,756 million (up 37.1% year-on-year). Net income attributable to owners of parent was ¥10,518 million (up 35.6% year-onyear). Despite the drastically changing environment, we steadily demonstrated our strengths in “Adaptability”, and both our foundation businesses (Vinyls and Chlor-Alkali, Modifiers, Performance Fibers, etc.) and leading-edge businesses (Health Care Solutions Unit, E & I Technology, Modified Silicone polymers, etc.) have kept up their strong momentum, resulting in a year-on-year increase in sales and profits.